T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.99% |
| 2 | Healthcare | 16.87% |
| 3 | Consumer Discretionary | 15.81% |
| 4 | Financials | 11.47% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Aprea Therapeutics
APRE
$8.42M
| $7.32M | ﹤0.01% |
15,208
-532
| -3% | -$298K |
|
|
VMW
1352
DELISTED
VMware, Inc
VMW
| $7.3M | ﹤0.01% |
50,782
-1,977,307
| -97% | -$281M |
|
|
AMK
1353
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $7.27M | ﹤0.01% |
334,582
| – | – |
|
|
MASI
1354
DELISTED
Masimo
MASI
| $7.25M | ﹤0.01% |
30,703
-257,739
| -89% | -$57.8M |
|
1355
Immunovant
IMVT
$8.55B
| $7.23M | ﹤0.01% |
+205,550
| New | +$6.18M |
|
1356
Harmony Biosciences
HRMY
$2.22B
| $7.1M | ﹤0.01% |
+209,361
| New | +$7.63M |
|
1357
United Parks & Resorts
PRKS
$2.05B
| $7.07M | ﹤0.01% |
358,454
+344,085
| +2,395% | +$6.28M |
|
1358
Liberty Media Series C
FWONK
$26.3B
| $7.06M | ﹤0.01% |
201,376
+2,462
| +1% | +$86.6K |
|
1359
Health Catalyst
HCAT
$141M
| $6.75M | ﹤0.01% |
184,283
-156,607
| -46% | -$5.32M |
|
1360
NNN REIT
NNN
$8.88B
| $6.54M | ﹤0.01% |
189,369
+7,942
| +4% | +$284K |
|
1361
Unum
UNM
$14.8B
| $6.49M | ﹤0.01% |
385,544
-12,706
| -3% | -$226K |
|
|
AMRN
1362
Amarin Corp
AMRN
$296M
| $6.48M | ﹤0.01% |
77,010
-482,206
| -86% | -$57.8M |
|
|
CDK
1363
DELISTED
CDK Global, Inc.
CDK
| $6.43M | ﹤0.01% |
147,516
-137,414
| -48% | -$6.11M |
|
1364
SolarEdge
SEDG
$2.02B
| $6.39M | ﹤0.01% |
26,819
+1,642
| +7% | +$316K |
|
1365
Sensata Technologies
ST
$6.68B
| $6.39M | ﹤0.01% |
148,171
-9,965,774
| -99% | -$405M |
|
1366
Warner Bros
WBD
$69.6B
| $6.39M | ﹤0.01% |
293,441
-6,414
| -2% | -$140K |
|
|
DS
1367
DELISTED
Drive Shack Inc.
DS
| $6.38M | ﹤0.01% |
5,699,844
| – | – |
|
1368
Aspen Aerogels
ASPN
$492M
| $6.36M | ﹤0.01% |
+580,566
| New | +$4.59M |
|
1369
Restaurant Brands International
QSR
$26.8B
| $6.2M | ﹤0.01% |
107,762
-423,874
| -80% | -$23.6M |
|
|
ODT
1370
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $6.18M | ﹤0.01% |
460,159
-568,979
| -55% | -$16.1M |
|
1371
Dell
DELL
$318B
| $6.17M | ﹤0.01% |
179,981
+38,900
| +28% | +$1.21M |
|
|
GAP
1372
The Gap Inc
GAP
$7.4B
| $6.12M | ﹤0.01% |
359,472
-12,615
| -3% | -$188K |
|
1373
Liberty Global Class C
LBTYK
$3.53B
| $6.11M | ﹤0.01% |
297,500
-36,500
| -11% | -$802K |
|
|
PSTH.WS
1374
DELISTED
Pershing Square Tontine Holdings, Ltd. Warrants, exercisable for one share of Class A Common Stock f
PSTH.WS
| $6.11M | ﹤0.01% |
+851,688
| New | +$6.15M |
|
1375
Berkshire Hathaway Class A
BRK.A
$1.08T
| $6.08M | ﹤0.01% |
19
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.